Lee Sung Insider Trades

Insider Trading History

Track insider trading activity for Lee Sung. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $2.19M 26,709 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$94.8k 1,112 shares
$85.26
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.18M 63,221 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$97.6k 1,112 shares
$87.79
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.27M 64,333 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$94.8k 1,112 shares
$85.26
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $4.29M 52,304 shares
Last Trade
Jun 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$273k 3,134 shares
$87.26
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.44M 66,355 shares
Last Trade
Jun 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$273k 3,134 shares
$87.26
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.18M 63,221 shares
Last Trade
Jun 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$266k 3,134 shares
$85.00
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $8.35M 101,951 shares
Last Trade
Jun 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.14M 38,730 shares
$81.20
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $2.62M 32,019 shares
Last Trade
Jun 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.14M 38,730 shares
$81.20
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.18M 63,221 shares
Last Trade
Jun 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.19M 38,730 shares
$82.30
$81.93
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $678k 22,870 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.7k 4,140 shares
$20.22
$29.65
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.18M 63,221 shares
Last Trade
May 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.84M 23,906 shares
$76.87
$81.93
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $661k 22,300 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 17,500 shares
$22.06
$29.65
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $7.14M 87,127 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$307k 4,935 shares
$62.15
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $7.54M 92,062 shares
Last Trade
Mar 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.11M 51,791 shares
$60.06
$81.93
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $1.78M 60,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$597k 70,000 shares
$8.53
$29.65
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.92M 72,221 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 4,304 shares
$65.60
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.85M 71,416 shares
Last Trade
Dec 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.5k 805 shares
$62.72
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.56M 67,917 shares
Last Trade
Dec 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$101k 1,560 shares
$65.02
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.69M 69,477 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$155k 4,965 shares
$31.21
$81.93
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $6.1M 74,442 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.23M 50,342 shares
$44.36
$81.93

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up